prasinezumab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for prasinezumab, covering 2021-02-08 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease [Phase 3]